[5] Sleep Architecture Modulation : Animal and limited human studies indicate that DSIP may increase the duration of slow-wave sleep without significantly affecting rapid eye movement (REM) sleep, which could support improved restorative sleep and cognitive function
Epithalon is not approved by the FDA, EMA, or any other regulatory authority for any indication
Cross-body-of-evidence comparisons are inherently weaker than a controlled head-to-head, and readers should hold the topical wins on evidence conclusion as a statement about what has been studied , not a proven verdict that topical outperforms injection
Fibronectin bridges monocytes and reticulocytes via integrin 41
after 7 days of treatment, they were 10.93, 9.94, and 9.11 g/dl, respectively, and after 14 days, they were 11.84, 10.97, and 10.41 g/dl, respectively, in comparison to groups 2, 3, and 4